Guardant Health Inc. Common Stock vs Medline Inc. Class A Common Stock — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B). The key difference: Medline Inc. Class A Common Stock is the larger of the two by market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Medline Inc. Class A Common Stock for 0 Days on average.
| GH | MDLN | |
|---|---|---|
Market Cap | $22.58B | $31.10B |
Volume | 2,200,599 | 4,471,639 |
Sector | Health | Health |
52-Week High | $187.22 | $49.99 |
52-Week Low | $61.73 | $31.64 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $23.22B | $41.07B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →